4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 100mg

3-Aminobenzotrifluoride>99.0%(GC)25g

(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid, 97.0%, 10mg

2-BROMO-5-METHOXY-4-METHYLBENZOIC ACID, 95.0%, 5g

(2S,4S)-1-(tert-Butoxycarbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 95.0%, 1g

1-(5-Bromopyridin-2-yl)piperazine hydrochloride, 95.0%, 1g

H-D-GLUTAMIC AICD DIETHYL ESTER HCL, 97.0%, 10g

METHYL 4-BROMO-2-(DIBROMOMETHYL)-6-FLUOROBENZOATE, 95%, 1g

2-Fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 250mg

Methyl 2-amino-4-bromo-5-fluorobenzoate, 95.0%, 25g

ETHYL 1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLE-4-CARBOXYLATE, 95%, 100mg

Pumice stone, 2-5 mm, 5 kg, plastic packaging.

3-Ethoxy-N,N-dimethyl-2-nitrobenzenamine, 250mg